Oral maribavir for treatment of refractory or resistant cytomegalovirus infections in transplant recipients (Q37777434)

23 August 2017

title

Oral maribavir for treatment of refractory or resistant cytomegalovirus infections in transplant recipients (English)

1 reference

23 August 2017

0 references

cytomegaloviral disease

1 reference

based on heuristic

inferred from title

viral drug resistance

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20682012

16 June 2024

2

F. M. Marty

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20682012

16 June 2024

author name string

R. K. Avery

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20682012

16 June 2024

L. Strasfeld

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20682012

16 June 2024

I. Lee

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20682012

16 June 2024

A. Arrieta

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20682012

16 June 2024

S. Chou

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20682012

16 June 2024

W. Tatarowicz

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20682012

16 June 2024

S. Villano

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20682012

16 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20682012

16 June 2024

publication date

1 December 2010

1 reference

full work available at URL

23 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1399-3062.2010.00550.x

1 reference

https://api.crossref.org/works/10.1111/J.1399-3062.2010.00550.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1399-3062.2010.00550.x/fullpdf

16 June 2024

1 reference

https://api.crossref.org/works/10.1111/J.1399-3062.2010.00550.X

Transplant Infectious Disease

16 June 2024

published in

1 reference

23 August 2017

volume

12

1 reference

23 August 2017

issue

6

1 reference

23 August 2017

page(s)

489-496

1 reference

23 August 2017

cites work

Controlling the troll

1

1 reference

https://api.crossref.org/works/10.1111/J.1399-3062.2010.00550.X

Persistent clinical impact of cytomegalovirus in organ transplantation.

16 June 2024

2

1 reference

https://api.crossref.org/works/10.1111/J.1399-3062.2010.00550.X

Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants.

16 June 2024

3

1 reference

https://api.crossref.org/works/10.1111/J.1399-3062.2010.00550.X

Cytomegalovirus (CMV) resistance to antivirals

16 June 2024

4

1 reference

https://api.crossref.org/works/10.1111/J.1399-3062.2010.00550.X

Clinical characteristics of 13 solid organ transplant recipients with ganciclovir-resistant cytomegalovirus infection

16 June 2024

5

1 reference

https://api.crossref.org/works/10.1111/J.1399-3062.2010.00550.X

Combination antiviral therapy for ganciclovir-resistant cytomegalovirus infection in solid-organ transplant recipients

16 June 2024

6

1 reference

https://api.crossref.org/works/10.1111/J.1399-3062.2010.00550.X

Update in management of ganciclovir-resistant cytomegalovirus infection

16 June 2024

7

1 reference

https://api.crossref.org/works/10.1111/J.1399-3062.2010.00550.X

Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action

16 June 2024

8

1 reference

https://api.crossref.org/works/10.1111/J.1399-3062.2010.00550.X

Inhibition of human cytomegalovirus replication by benzimidazole nucleosides involves three distinct mechanisms

16 June 2024

9

1 reference

https://api.crossref.org/works/10.1111/J.1399-3062.2010.00550.X

Maribavir sensitivity of cytomegalovirus isolates resistant to ganciclovir, cidofovir or foscarnet

16 June 2024

10

1 reference

https://api.crossref.org/works/10.1111/J.1399-3062.2010.00550.X

Phase I safety and pharmacokinetic trials of 1263W94, a novel oral anti-human cytomegalovirus agent, in healthy and human immunodeficiency virus-infected subjects

16 June 2024

11

1 reference

https://api.crossref.org/works/10.1111/J.1399-3062.2010.00550.X

Virologic characterization of multidrug-resistant cytomegalovirus infection in 2 transplant recipients treated with maribavir

16 June 2024

14

1 reference

https://api.crossref.org/works/10.1111/J.1399-3062.2010.00550.X

Development of new cytomegalovirus UL97 and DNA polymerase mutations conferring drug resistance after valganciclovir therapy in allogeneic stem cell recipients

16 June 2024

15

1 reference

https://api.crossref.org/works/10.1111/J.1399-3062.2010.00550.X

High incidence of ganciclovir-resistant cytomegalovirus infection among lung transplant recipients receiving preemptive therapy

16 June 2024

16

1 reference

https://api.crossref.org/works/10.1111/J.1399-3062.2010.00550.X

Incidence and clinical features of ganciclovir-resistant cytomegalovirus disease in heart transplant recipients

16 June 2024

17

1 reference

https://api.crossref.org/works/10.1111/J.1399-3062.2010.00550.X

Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection

16 June 2024

19

1 reference

https://api.crossref.org/works/10.1111/J.1399-3062.2010.00550.X

Treatment of multidrug-resistant cytomegalovirus retinitis with systemically administered leflunomide

16 June 2024

20

1 reference

https://api.crossref.org/works/10.1111/J.1399-3062.2010.00550.X

16 June 2024

Identifiers

1 reference

23 August 2017

1 reference